Copyright © 1996, 2001 by Galen Daryl
Knight and VitaleTherapeutics, Inc.
References on Riboflavin's Protection Against Neoplasia
Kensler, C.J., Sugiura, K., Young, N.F., Halter, C.R., and Rhoads, C.P.
Partial protection of rats by riboflavin with casein against liver cancer
caused by dimethylaminoazobenzene. Science, 93: 308-310, 1941.
Griffin, A.C. and Baumann, C.A. Hepatic riboflavin and tumor formation
in rats fed azodyes in various diets. Cancer Res., 8:279-284, 1948.
Miller, E.C., Miller, J.A., Kline, B.E., Rusch, H.P. Correlation of the
level of hepatic riboflavin with the appearance of liver tumor in rats
fed aminoazodyes. J. Exp.. Med., 88: 89-98, 1948.
van Rensburg, S.J. Epidemiologic and dietary evidence for a specific nutritional
predisposition to esophageal cancer. J. Natl. Cancer Inst., 67:
Warwick, G.P., and Harington, J.S. Some aspects of the epidemiology and
etiology of esophageal cancer with particular emphasis on the Transkei,
South Africa. In: G. Klein and S. Weinhouse (eds.),
Res., Vol. 17, pp. 81-229. New York: Academic Press, 1973.
Aboobaker, V.S. and Bhattacharya, R.K. Modulation of flavocoenzyme levels
in rat tissues by N-nitrosodiethylamine. Cancer Lett., 44: 167-171,
Bhattacharya, R.K., Francis, A.R. and Shetty, T.K. Modifying role of dietary
factors on the mutagenicity of aflatoxin B1: In vitro effect of vitamins.
Mutat. Res., 188:121-128, 1987.
Bhattacharya, R.K., Firozi, P.F., and Aboobaker, V.S. Factors modulating
the formation of DNA adduct by aflatoxin B1 in vitro. Carcinogenesis,
5: 1359-1362, 1984.